Lumefantrine manufactured by Micro Labs Ltd and Lopinavir manufactured by Acebright (India) Pharma Pvt Ltd have been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.
-
WHOAPI-217 - Lumefantrine - Micro Labs Ltd - INDIA - FPPs containing lumefantrine are used in the therapeutic area of malaria
-
WHOAPI-258 - Lopinavir - Acebright (India) Pharma Pvt Ltd - INDIA - FPPs containing lopinavir are used in the therapeutic area of HIV/AIDS
Good-quality APIs are vital to the production of good-quality medicines. WHO prequalification of APIs will facilitate production of quality medicines by identifying such APIs for use by manufacturers of finished pharmaceutical products (FPPs).
API prequalification consists of a comprehensive evaluation procedure that has two components: assessment of the API master file (APIMF) to verify compliance with WHO norms and standards, and evaluation of the sites of API manufacture to verify compliance with WHO GMP requirements.